Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |